πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Patent portfolio

Regeneron Ireland Designated Patents

Full USPTO pharma patent portfolio for Regeneron Ireland Designated β€” grant dates, expiration, and drug cross-links.

Patents
8,292
Expiring ≀24m
426

Quick answer

Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β€” use filters for patent-cliff planning.

Page 114 of 173

  1. US 8324181

    Modulation of gene expression by oligomers targeted to chromosomal DNA

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8323665

    Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8323635

    Methods of using interleukin-1 receptor antagonist as a myeloprotective agent

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8324178

    Method of treatment using alpha-1-adrenergic agonist compounds

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8323906

    Compositions, kits, and methods for identification, assessment, prevention and therapy of breast and ovarian cancer

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8324169

    VEGF-activated ligands

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8318483

    Postpartum cells derived from umbilical cord tissue, and methods of making and using the same

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8318700

    Lung-targeted drugs

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8318945

    Metalloprotein inhibitors

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8318951

    Stem cell differentiating agents and uses therefor

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8318906

    EMP2 antibodies and their therapeutic uses

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8318817

    Controlled release antimicrobial compositions and methods for the treatment of otic disorders

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8318490

    Prelamin A pre peptide as a universal stem cell differentiation signal

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8318156

    Anti-cocaine compositions and treatment

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8318182

    Vault compositions for immunization against Chlamydia genital infection

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8309595

    Hydrazone modulators of cannabinoid receptors

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8309565

    Phosphonate compounds

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8309525

    Treatment of type 2 diabetes, metabolic syndrome, myocardial injury and neurodegeneration with humanin and analogs thereof

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8309350

    Photoreactive regulator of protein function and methods of use thereof

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8309070

    Use of umbilical cord blood stem cells to treat ischemic event

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8309355

    Methods of treating Parkinson's disease using viral vectors

    Expires Mon Nov 08 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8303995

    Nitrite formulations and their use as nitric oxide prodrugs

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8304247

    Recognitive hydrogel

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8304526

    Antitumor effect of mutant Bik

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8304408

    Wnt signaling inhibitors, and methods for making and using them

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8304399

    Hedgehog signaling pathway proteins and uses thereof

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8304397

    Identification of a micro-RNA that activates expression of Ξ²-myosin heavy chain

    Expires Mon Nov 01 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8298521

    Treatment for eye disorder

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8299218

    Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8299040

    Methods for treating cancer targeting transglutaminase

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8299033

    Iodo-hexose compounds useful to treat cancer

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8298589

    Nitrite formulations and their use as nitric oxide prodrugs

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8298542

    Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8298556

    Methods and related compositions for the non-surgical removal of fat

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8299046

    Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8298606

    Methods and compositions for stabilizing the myocardium

    Expires Mon Oct 25 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8293275

    Spray freeze dry of compositions for pulmonary administration

    Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8293776

    Compositions and methods for treating inflammatory conditions of the bowel

    Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8293240

    Method of treating drug-resistant cancer

    Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 8293764

    Compositions and methods for disruption of BRCA2-Rad51 interaction

    Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 8287879

    Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 8283368

    Selective ligands for the dopamine 3 (D3) receptor and methods of using the same

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 8283458

    VMP-like sequences of pathogenic Borrelia species and strains

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 8283114

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 8283308

    Copolymer-stabilized emulsions

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 8282937

    Cold-adapted (CA) reassortant influenza virus

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 8282963

    Methods for extracting platelets and compositions obtained therefrom

    Expires Mon Oct 04 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 8277796

    Regeneration and repair of neural tissue using postpartum-derived cells

    Expires Mon Sep 27 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Regeneron Ireland Designated have?

8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Regeneron Ireland Designated patents expire?

426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources Β· Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates β€” weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.